RFA-DA-24-064 - HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 1
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Change to Key Dates for RFA-DA-23-032, "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)" | NOT-DA-22-067 | NIDA | Aug 23, 2022 | n/a | R21 |